Open AccessThe efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
Author(s) -
Ying Guan,
Anchuan Li,
Weiwei Xiao,
Shuai Liu,
Binbin Chen,
TaiXiang Lu,
Chong Zhao,
Fei Han
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.5271
Subject(s) - medicine , nasopharyngeal carcinoma , chemoradiotherapy , radiation therapy , oncology , incidence (geometry) , chemotherapy , gastroenterology , surgery , physics , optics
To evaluate the short-term efficacy and safety of recombinant human endostatin (Endostar) combined with chemoradiotherapy for the treatment of advanced, locally recurrent nasopharyngeal carcinoma (NPC).